News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Numerate Awarded U.S. Department of Defense Contract to Extend Drug Design Platform


9/9/2010 12:11:21 PM

SAN BRUNO, Calif.--(BUSINESS WIRE)--Numerate, Inc. announced today that it has been awarded a new three-year contract by the Defense Threat Reduction Agency (DTRA), an agency within the U.S. Department of Defense, to adapt its pioneering small-molecule drug design platform to the rapid design and optimization of drugs against biowarfare agents.

Read at BioSpace.com

comments powered by Disqus
Numerate
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES